![Joseph Shulman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Shulman
Chief Tech/Sci/R&D Officer at
RHYTHM PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 29/06/2026
Profile
Joseph Shulman is Chief Technical Officer at Rhythm Pharmaceuticals, Inc. since 2022, with employment at the company starting in 2020.
Formerly, Mr. Shulman was Senior Vice President-Technical Operations at RA Pharmaceuticals, Inc. from 2019 to 2020 and Senior Vice President-Global Technical Operations at Novelion Therapeutics, Inc. from 2014 to 2019.
Education includes an MBA from Boston University and an undergraduate degree from the University of Miami.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/02/2026 | 18,970 ( 0.03% ) | 2 M $ | 29/06/2026 |
Joseph Shulman active positions
| Companies | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 26/07/2020 |
Former positions of Joseph Shulman
| Companies | Position | End |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/06/2020 |
| NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 30/06/2019 |
Training of Joseph Shulman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
- Stock Market
- Insiders
- Joseph Shulman
Choose MarketScreener 
